Deanna A. Sutton - Concepedia

Author

Deanna A. Sutton

The University of Texas Health Science Center at San Antonio

Also Known As

D A Sutton, D Sutton, D. A. SUTTON, D. A. Sutton, D. Sutton, D.A. Sutton, DEANNA A. SUTTON, Deanna A Sutton, Deanna A. Sutton, Deanna Sutton

196

Publications

11.5K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio Universitat Rovira i Virgili Institut d'Investigació Sanitària Pere Virgili Murphy Oil Corporation (United States)South Texas Veterans Health Care System

About

Deanna A. Sutton is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	68	3.6K
2	Health Sciences	17	18	1.5K
3	Natural Sciences	9	9	606
4	Engineering	4	4	144
5	Public Health	1	1	141

Deanna A. Sutton

116

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
<i>Sporothrix brasiliensis</i>,<i>S. globosa</i>, and<i>S. mexicana</i>, Three New<i>Sporothrix</i>Species of Clinical Interest Rita Marimon, J. Cano, Josepa Gené, Journal of Clinical Microbiology	2007	507
Necrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011 Robyn Neblett Fanfair, Kaitlin Benedict, John Bos, New England Journal of Medicine	2012	359
In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents Nikolaos G. Almyroudis, Deanna A. Sutton, Annette W. Fothergill, Antimicrobial Agents and Chemotherapy Antifungal AgentHealth SciencesFungal PathogenAntifungal AgentsVitro Susceptibilities	2007	283
Experimental Pulmonary Aspergillosis Due to<i>Aspergillus terreus:</i>Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B Thomas J. Walsh, Vidmantas Petraitis, Rūta Petraitienė, The Journal of Infectious Diseases Aspergillus TerreusAntifungal AgentHealth SciencesAntifungal AgentsResidual Fungal Burden	2003	255
In Vitro Amphotericin B Resistance in Clinical Isolates of <i>Aspergillus terreus</i> , with a Head-to-Head Comparison to Voriconazole Deanna A. Sutton, Stephen Sanche, Sanjay G. Revankar, Journal of Clinical Microbiology	1999	251
Spectrum of Clinically Relevant<i>Exophiala</i>Species in the United States Jianhua Zeng, Deanna A. Sutton, Annette W. Fothergill, Journal of Clinical Microbiology	2007	233
Molecular and Phenotypic Data Supporting Distinct Species Statuses for <i>Scedosporium apiospermum</i> and <i>Pseudallescheria boydii</i> and the Proposed New Species <i>Scedosporium dehoogii</i> Félix Gilgado, J. Cano, Josepa Gené, Journal of Clinical Microbiology	2007	227
Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients with<i>Candida</i>Fungemia M. Hong Nguyen, Cornelius J. Clancy, Victor L. Yu, The Journal of Infectious Diseases Microbial PathogensClinical MycologyAntimicrobial ChemotherapyDrug ResistanceAmphotericin B	1998	219
Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against <i>Candida</i> and <i>Aspergillus</i> Species Frank C. Odds, Mary Motyl, Roberto Andrade, Journal of Clinical Microbiology MycologyDiagnostic MycologyAntifungal AgentSusceptibility TestingAntifungal Agents	2004	173
Spectrum of Zygomycete Species Identified in Clinically Significant Specimens in the United States Eduardo Álvarez, Deanna A. Sutton, J. Cano, Journal of Clinical Microbiology BiologyMycologyClinically Significant SpecimensPhylogeneticsOrder Mucorales	2009	166

Page 1